A Long-term Follow-up Study of FOLFIRINOX Regimen as Adjuvant Therapy in Pancreatic Cancer Patients After Curative Surgery: Multi-center, Prospective
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
This study is designed to evaluate the safety and efficacy of adjuvant FOLFIRINOX regimen in pancreatic cancer patients after curative surgery.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 19
Healthy Volunteers: f
View:
• Age over 19 at the time of obtaining the informed consent form
• Planning to FOLFIRINOX as adjuvant therapy after pancreatic cancer surgery
• ECOG 0 or 1
• Scheduled to RO or R1 resection
• Organ function capable of chemotherapy
Locations
Other Locations
Republic of Korea
Seoul ST. Mary's Hospital
RECRUITING
Seoul
Contact Information
Primary
Soyeon Ahn
soyeon.ahn@inno-n.com
82-2-6477-0252
Backup
Yongan Jeong
yongan.jeong@inno-n.com
82-2-6477-0255
Time Frame
Start Date: 2023-09-25
Estimated Completion Date: 2027-12
Participants
Target number of participants: 36
Related Therapeutic Areas
Sponsors
Leads: HK inno.N Corporation